Literature DB >> 25802278

Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.

Julie L Frey1, Zhu Li1, Jessica M Ellis2, Qian Zhang1, Charles R Farber3, Susan Aja4, Michael J Wolfgang5, Thomas L Clemens6, Ryan C Riddle7.   

Abstract

The Wnt coreceptors Lrp5 and Lrp6 are essential for normal postnatal bone accrual and osteoblast function. In this study, we identify a previously unrecognized skeletal function unique to Lrp5 that enables osteoblasts to oxidize fatty acids. Mice lacking the Lrp5 coreceptor specifically in osteoblasts and osteocytes exhibit the expected reductions in postnatal bone mass but also exhibit an increase in body fat with corresponding reductions in energy expenditure. Conversely, mice expressing a high bone mass mutant Lrp5 allele are leaner with reduced plasma triglyceride and free fatty acid levels. In this context, Wnt-initiated signals downstream of Lrp5, but not the closely related Lrp6 coreceptor, regulate the activation of β-catenin and thereby induce the expression of key enzymes required for fatty acid β-oxidation. These results suggest that Wnt-Lrp5 signaling regulates basic cellular activities beyond those associated with fate specification and differentiation in bone and that the skeleton influences global energy homeostasis via mechanisms independent of osteocalcin and glucose metabolism.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25802278      PMCID: PMC4420919          DOI: 10.1128/MCB.01343-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  80 in total

1.  Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes.

Authors:  Lige Song; Minlin Liu; Noriaki Ono; F Richard Bringhurst; Henry M Kronenberg; Jun Guo
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

2.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

3.  Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.

Authors:  Michael S Ominsky; Chaoyang Li; Xiaodong Li; Hong L Tan; Edward Lee; Mauricio Barrero; Franklin J Asuncion; Denise Dwyer; Chun-Ya Han; Fay Vlasseros; Rana Samadfam; Jacquelin Jolette; Susan Y Smith; Marina Stolina; David L Lacey; William S Simonet; Chris Paszty; Gang Li; Hua Z Ke
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

4.  LRP6 mutation in a family with early coronary disease and metabolic risk factors.

Authors:  Arya Mani; Jayaram Radhakrishnan; He Wang; Alaleh Mani; Mohammad-Ali Mani; Carol Nelson-Williams; Khary S Carew; Shrikant Mane; Hossein Najmabadi; Dan Wu; Richard P Lifton
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

5.  Short stature in anorexia nervosa patients.

Authors:  M Nussbaum; D Baird; M Sonnenblick; K Cowan; I R Shenker
Journal:  J Adolesc Health Care       Date:  1985-11

6.  The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice.

Authors:  Olivia G Kelly; Kathy I Pinson; William C Skarnes
Journal:  Development       Date:  2004-05-13       Impact factor: 6.868

7.  A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E.

Authors:  D H Kim; Y Inagaki; T Suzuki; R X Ioka; S Z Yoshioka; K Magoori; M J Kang; Y Cho; A Z Nakano; Q Liu; T Fujino; H Suzuki; H Sasano; T T Yamamoto
Journal:  J Biochem       Date:  1998-12-01       Impact factor: 3.387

8.  Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.

Authors:  Kenta Magoori; Man-Jong Kang; Mitsuko R Ito; Hajime Kakuuchi; Ryoichi X Ioka; Akihisa Kamataki; Dong-Ho Kim; Hiroshi Asaba; Satoshi Iwasaki; Yumiko A Takei; Masako Sasaki; Shinichi Usui; Mitsuyo Okazaki; Sadao Takahashi; Masao Ono; Masato Nose; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-31       Impact factor: 5.157

Review 9.  The contribution of bone to whole-organism physiology.

Authors:  Gérard Karsenty; Mathieu Ferron
Journal:  Nature       Date:  2012-01-18       Impact factor: 69.504

10.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

View more
  56 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 2.  Regulation of Energy Metabolism by Bone-Derived Hormones.

Authors:  Paula Mera; Mathieu Ferron; Ioanna Mosialou
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 3.  Metabolic regulation of skeletal cell fate and function in physiology and disease.

Authors:  Nick van Gastel; Geert Carmeliet
Journal:  Nat Metab       Date:  2021-01-04

4.  Intracellular lipid droplets support osteoblast function.

Authors:  Elizabeth Rendina-Ruedy; Anyonya R Guntur; Clifford J Rosen
Journal:  Adipocyte       Date:  2017-07-20       Impact factor: 4.534

5.  Exercise Decreases Marrow Adipose Tissue Through ß-Oxidation in Obese Running Mice.

Authors:  Maya Styner; Gabriel M Pagnotti; Cody McGrath; Xin Wu; Buer Sen; Gunes Uzer; Zhihui Xie; Xiaopeng Zong; Martin A Styner; Clinton T Rubin; Janet Rubin
Journal:  J Bone Miner Res       Date:  2017-05-04       Impact factor: 6.741

6.  Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation.

Authors:  Seung-Yon Lee; Fanxin Long
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 14.808

Review 7.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

8.  Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo.

Authors:  Ji-jie Xiao; Wen-ji Zhao; Xin-tao Zhang; Wen-long Zhao; Xiao-xia Wang; Shu-hui Yin; Fang Jiang; Yin-xia Zhao; Fang-ni Chen; Shao-lin Li
Journal:  Mol Cell Biochem       Date:  2015-07-19       Impact factor: 3.396

9.  Lowering circulating apolipoprotein E levels improves aged bone fracture healing.

Authors:  Rong Huang; Xiaohua Zong; Puviindran Nadesan; Janet L Huebner; Virginia B Kraus; James P White; Phillip J White; Gurpreet S Baht
Journal:  JCI Insight       Date:  2019-09-19

Review 10.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.